Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Corcept Therapeutics (CORT) Exchange Rate Effect (2024 - 2025)

Corcept Therapeutics (CORT) has disclosed Exchange Rate Effect for 2 consecutive years, with -$32000.0 as the latest value for Q4 2025.

  • Quarterly Exchange Rate Effect rose 95.78% to -$32000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$574000.0 through Dec 2025, changed N/A year-over-year, with the annual reading at $1.4 million for FY2025, 732.46% up from the prior year.
  • Exchange Rate Effect hit -$32000.0 in Q4 2025 for Corcept Therapeutics, up from -$320000.0 in the prior quarter.
  • In the past five years, Exchange Rate Effect ranged from a high of $536000.0 in Q3 2024 to a low of -$758000.0 in Q4 2024.